Abstract
The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration).
| Original language | English |
|---|---|
| Patent number | EP3446120 |
| Publication status | Published - 2019 |
Fingerprint
Dive into the research topics of 'A new biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells'. Together they form a unique fingerprint.Projects
- 2 Finished
-
SRP50: SRP-Onderzoekszwaartepunt: Exploiting Peptides: Protein Binders, Modulators and Inhibitors for Imaging and Therapy [Exploit-PeptIT]
Ballet, S. (Administrative Promotor), Caveliers, V. (Co-Promotor), Hernot, S. (Co-Promotor), Versées, W. (Co-Promotor), Vinken, M. (Co-Promotor), Muyldermans, S. (Co-Promotor), Devoogdt, N. (Co-Promotor), Bridoux, J. (Collaborator) & Martin, C. (Collaborator)
1/03/19 → 30/09/25
Project: Fundamental
-
FWOSBO21: SBO: MATATUM : Validation and druggability development of macrophage-specific targets in the tumor microenvironment
Van Ginderachter, J. (Administrative Promotor), Breckpot, K. (Co-Promotor), Lahoutte, T. (Co-Promotor), Devoogdt, N. (Co-Promotor) & Raes, G. (Co-Promotor)
1/01/18 → 31/12/21
Project: Applied
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver